Chronic heroin use disorder and the brain: Current evidence and future implications

The incidence of chronic heroin use disorder, including overdose deaths, has reached epidemic proportions. Here we summarise and evaluate our knowledge of the relationship between chronic heroin use disorder and the brain through a narrative review. A broad range of areas was considered including ca...

Full description

Saved in:
Bibliographic Details
Published inProgress in neuro-psychopharmacology & biological psychiatry Vol. 111; p. 110148
Main Authors Tolomeo, Serenella, Steele, J. Douglas, Ekhtiari, Hamed, Baldacchino, Alex
Format Journal Article
LanguageEnglish
Published England Elsevier Inc 20.12.2021
Subjects
Online AccessGet full text
ISSN0278-5846
1878-4216
1878-4216
DOI10.1016/j.pnpbp.2020.110148

Cover

Abstract The incidence of chronic heroin use disorder, including overdose deaths, has reached epidemic proportions. Here we summarise and evaluate our knowledge of the relationship between chronic heroin use disorder and the brain through a narrative review. A broad range of areas was considered including causal mechanisms, cognitive and neurological consequences of chronic heroin use and novel neuroscience-based clinical interventions. Chronic heroin use is associated with limited or very limited evidence of impairments in memory, cognitive impulsivity, non-planning impulsivity, compulsivity and decision-making. Additionally, there is some evidence for certain neurological disorders being caused by chronic heroin use, including toxic leukoencephalopathy and neurodegeneration. However, there is insufficient evidence on whether these impairments and disorders recover after abstinence. Whilst there is a high prevalence of comorbid psychiatric disorders, there is no clear evidence that chronic heroin use per se causes depression, bipolar disorder, PTSD and/or psychosis. Despite the growing burden on society from heroin use, knowledge of the long-term effects of chronic heroin use disorder on the brain remains limited. Nevertheless, there is evidence for progress in neuroscience-based interventions being made in two areas: assessment (cognitive assessment and neuroimaging) and interventions (cognitive training/remediation and neuromodulation). Longitudinal studies are needed to unravel addiction and neurotoxic mechanisms and clarify the role of pre-existing psychiatric symptoms and cognitive impairments. •The relationship between chronic heroin use disorder and the brain remains unclear because of the paucity of high-quality studies.•Chronic heroin use is associated with structural, functional and cognitive impairments.•Tailored treatments with clinical translation and implementation neuroscience are discussed.
AbstractList The incidence of chronic heroin use disorder, including overdose deaths, has reached epidemic proportions. Here we summarise and evaluate our knowledge of the relationship between chronic heroin use disorder and the brain through a narrative review. A broad range of areas was considered including causal mechanisms, cognitive and neurological consequences of chronic heroin use and novel neuroscience-based clinical interventions. Chronic heroin use is associated with limited or very limited evidence of impairments in memory, cognitive impulsivity, non-planning impulsivity, compulsivity and decision-making. Additionally, there is some evidence for certain neurological disorders being caused by chronic heroin use, including toxic leukoencephalopathy and neurodegeneration. However, there is insufficient evidence on whether these impairments and disorders recover after abstinence. Whilst there is a high prevalence of comorbid psychiatric disorders, there is no clear evidence that chronic heroin use per se causes depression, bipolar disorder, PTSD and/or psychosis. Despite the growing burden on society from heroin use, knowledge of the long-term effects of chronic heroin use disorder on the brain remains limited. Nevertheless, there is evidence for progress in neuroscience-based interventions being made in two areas: assessment (cognitive assessment and neuroimaging) and interventions (cognitive training/remediation and neuromodulation). Longitudinal studies are needed to unravel addiction and neurotoxic mechanisms and clarify the role of pre-existing psychiatric symptoms and cognitive impairments.The incidence of chronic heroin use disorder, including overdose deaths, has reached epidemic proportions. Here we summarise and evaluate our knowledge of the relationship between chronic heroin use disorder and the brain through a narrative review. A broad range of areas was considered including causal mechanisms, cognitive and neurological consequences of chronic heroin use and novel neuroscience-based clinical interventions. Chronic heroin use is associated with limited or very limited evidence of impairments in memory, cognitive impulsivity, non-planning impulsivity, compulsivity and decision-making. Additionally, there is some evidence for certain neurological disorders being caused by chronic heroin use, including toxic leukoencephalopathy and neurodegeneration. However, there is insufficient evidence on whether these impairments and disorders recover after abstinence. Whilst there is a high prevalence of comorbid psychiatric disorders, there is no clear evidence that chronic heroin use per se causes depression, bipolar disorder, PTSD and/or psychosis. Despite the growing burden on society from heroin use, knowledge of the long-term effects of chronic heroin use disorder on the brain remains limited. Nevertheless, there is evidence for progress in neuroscience-based interventions being made in two areas: assessment (cognitive assessment and neuroimaging) and interventions (cognitive training/remediation and neuromodulation). Longitudinal studies are needed to unravel addiction and neurotoxic mechanisms and clarify the role of pre-existing psychiatric symptoms and cognitive impairments.
The incidence of chronic heroin use disorder, including overdose deaths, has reached epidemic proportions. Here we summarise and evaluate our knowledge of the relationship between chronic heroin use disorder and the brain through a narrative review. A broad range of areas was considered including causal mechanisms, cognitive and neurological consequences of chronic heroin use and novel neuroscience-based clinical interventions. Chronic heroin use is associated with limited or very limited evidence of impairments in memory, cognitive impulsivity, non-planning impulsivity, compulsivity and decision-making. Additionally, there is some evidence for certain neurological disorders being caused by chronic heroin use, including toxic leukoencephalopathy and neurodegeneration. However, there is insufficient evidence on whether these impairments and disorders recover after abstinence. Whilst there is a high prevalence of comorbid psychiatric disorders, there is no clear evidence that chronic heroin use per se causes depression, bipolar disorder, PTSD and/or psychosis. Despite the growing burden on society from heroin use, knowledge of the long-term effects of chronic heroin use disorder on the brain remains limited. Nevertheless, there is evidence for progress in neuroscience-based interventions being made in two areas: assessment (cognitive assessment and neuroimaging) and interventions (cognitive training/remediation and neuromodulation). Longitudinal studies are needed to unravel addiction and neurotoxic mechanisms and clarify the role of pre-existing psychiatric symptoms and cognitive impairments.
The incidence of chronic heroin use disorder, including overdose deaths, has reached epidemic proportions. Here we summarise and evaluate our knowledge of the relationship between chronic heroin use disorder and the brain through a narrative review. A broad range of areas was considered including causal mechanisms, cognitive and neurological consequences of chronic heroin use and novel neuroscience-based clinical interventions. Chronic heroin use is associated with limited or very limited evidence of impairments in memory, cognitive impulsivity, non-planning impulsivity, compulsivity and decision-making. Additionally, there is some evidence for certain neurological disorders being caused by chronic heroin use, including toxic leukoencephalopathy and neurodegeneration. However, there is insufficient evidence on whether these impairments and disorders recover after abstinence. Whilst there is a high prevalence of comorbid psychiatric disorders, there is no clear evidence that chronic heroin use per se causes depression, bipolar disorder, PTSD and/or psychosis. Despite the growing burden on society from heroin use, knowledge of the long-term effects of chronic heroin use disorder on the brain remains limited. Nevertheless, there is evidence for progress in neuroscience-based interventions being made in two areas: assessment (cognitive assessment and neuroimaging) and interventions (cognitive training/remediation and neuromodulation). Longitudinal studies are needed to unravel addiction and neurotoxic mechanisms and clarify the role of pre-existing psychiatric symptoms and cognitive impairments. •The relationship between chronic heroin use disorder and the brain remains unclear because of the paucity of high-quality studies.•Chronic heroin use is associated with structural, functional and cognitive impairments.•Tailored treatments with clinical translation and implementation neuroscience are discussed.
ArticleNumber 110148
Author Steele, J. Douglas
Tolomeo, Serenella
Ekhtiari, Hamed
Baldacchino, Alex
Author_xml – sequence: 1
  givenname: Serenella
  surname: Tolomeo
  fullname: Tolomeo, Serenella
  email: fasst@nus.edu.sg
  organization: Department of Psychology, National University of Singapore (NUS), Singapore
– sequence: 2
  givenname: J. Douglas
  surname: Steele
  fullname: Steele, J. Douglas
  organization: School of Medicine, University of Dundee and Department of Neurology, NHS Tayside, Ninewells Hospital and Medical School, UK
– sequence: 3
  givenname: Hamed
  surname: Ekhtiari
  fullname: Ekhtiari, Hamed
  organization: Laureate Institute for Brain Research (LIBR), Tulsa, OK, USA
– sequence: 4
  givenname: Alex
  surname: Baldacchino
  fullname: Baldacchino, Alex
  organization: Division of Population and Behavioural Sciences, University of St Andrews, Fife, Scotland, United Kingdom
BackLink https://www.ncbi.nlm.nih.gov/pubmed/33169674$$D View this record in MEDLINE/PubMed
BookMark eNqFkE1rGzEQQEVJSWw3v6BQdOzFzugju9pADsW0ScDQQ3MXK2kWy6ylraQ19N9nbSc59NCeRozem8Obk4sQAxLymcGKAatudqshDGZYceDTZlpJ9YHMmKrVUnJWXZAZ8Ol9q2R1ReY57wCACRCX5EoIVjVVLWfk13qbYvCWbjFFH-iYkTqfY3KYaBscLVukJrU-3NH1mBKGQvHgHQaLp_9uLGNC6vdD721bfAz5E_nYtX3G69e5IM8_vj-vH5ebnw9P62-bpZUgy5KjkLXhljtmuk4pBVgZ2wJzKBtujBJga9OoBsAJITpTG-i4besapLG1WJCv57NDir9HzEXvfbbY923AOGbN5W0jZCMbNqFfXtHR7NHpIfl9m_7otw4TIM6ATTHnhN07wkAfa-udPtXWx9r6XHuymr8s68upQZmK9f9x788uToUOHpPO1h-rOp_QFu2i_6f_An0rm98
CitedBy_id crossref_primary_10_1016_j_jksus_2024_103329
crossref_primary_10_1016_j_neulet_2022_136532
crossref_primary_10_52827_hititmedj_1177407
crossref_primary_10_3390_biomedicines11071796
crossref_primary_10_7748_phc_2024_e1816
crossref_primary_10_1016_j_isci_2023_107536
crossref_primary_10_1080_10550887_2023_2168991
crossref_primary_10_62401_2531_4122_2024_62
crossref_primary_10_1016_j_jpsychires_2022_06_010
crossref_primary_10_1080_23279095_2024_2349682
crossref_primary_10_3390_brainsci14080754
crossref_primary_10_1016_j_bpsc_2023_11_002
crossref_primary_10_62401_2531_4122_2024_49
crossref_primary_10_3389_fmicb_2023_1283276
crossref_primary_10_3390_brainsci13111508
Cites_doi 10.31887/DCNS.2007.9.2/hkleber
10.1126/sciadv.aax9140
10.1038/npp.2013.289
10.1016/j.neurobiolaging.2015.07.018
10.1300/J069v10n03_07
10.1016/j.jpsychires.2016.04.001
10.1016/j.drugalcdep.2004.10.008
10.1038/bjp.2008.100
10.1080/09602011.2017.1391103
10.1007/s10484-013-9218-5
10.1016/j.biopsych.2003.09.011
10.1097/00008877-200209000-00008
10.1016/S0140-6736(17)32893-3
10.1016/j.sleep.2019.01.052
10.1007/s12016-013-8373-z
10.15585/mmwr.mm655051e1
10.3109/00952990.2010.543997
10.1111/ajad.12581
10.1007/s11065-007-9033-y
10.1159/000503952
10.1016/S0885-3924(03)00310-5
10.1016/j.drugalcdep.2012.05.030
10.1016/bs.pbr.2015.07.022
10.1177/155005941004100313
10.1016/j.drugalcdep.2007.05.025
10.1016/j.biopsych.2016.02.006
10.1016/S0893-133X(00)00209-8
10.1016/j.drugalcdep.2018.07.012
10.1016/S0893-133X(96)00184-4
10.1016/0304-3959(84)90884-4
10.1097/YCT.0000000000000568
10.3389/fpsyt.2019.00743
10.1016/j.euroneuro.2007.11.002
10.36076/ppj.2008/11/S133
10.1016/j.pnpbp.2017.09.007
10.3389/fpsyt.2019.00117
10.1176/appi.ajp.2007.07010070
10.1016/S0165-5728(97)00216-6
10.1016/j.neubiorev.2019.06.007
10.3389/fpsyt.2019.00877
10.1016/j.addbeh.2006.06.032
10.1016/j.bandc.2009.08.014
10.1016/S0733-8619(05)70357-1
10.1097/ADM.0000000000000022
10.1016/0376-8716(76)90037-5
10.1007/s00213-006-0632-8
10.1007/s00213-005-0198-x
10.1080/00952990.2018.1511725
10.1016/j.neubiorev.2012.06.006
10.1016/j.tics.2014.09.003
10.1038/sj.npp.1300812
10.1111/j.1360-0443.2009.02527.x
10.1038/nrn3119
10.1017/S0033291718003318
10.1016/j.drugalcdep.2005.11.008
10.1016/bs.pbr.2017.08.013
10.3389/fpsyt.2013.00135
10.1111/j.1600-0404.1990.tb01570.x
10.1037/1064-1297.3.4.432
10.1017/S0033291716001513
10.1177/1751143718774714
10.1089/jpm.2012.0270
10.1007/s00213-006-0515-z
10.1016/j.tins.2015.01.002
10.1016/S0092-8674(02)00666-9
10.1016/j.pscychresns.2004.04.001
10.1016/S2215-0366(16)00104-8
10.1111/j.1440-1819.2009.01989.x
10.1007/s11065-018-9393-5
10.1016/S0379-0738(99)00040-7
10.1111/j.1360-0443.2007.01823.x
10.1017/S0033291714002189
ContentType Journal Article
Copyright 2020 Elsevier Inc.
Copyright © 2020 Elsevier Inc. All rights reserved.
Copyright_xml – notice: 2020 Elsevier Inc.
– notice: Copyright © 2020 Elsevier Inc. All rights reserved.
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1016/j.pnpbp.2020.110148
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
MEDLINE

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Pharmacy, Therapeutics, & Pharmacology
EISSN 1878-4216
ExternalDocumentID 33169674
10_1016_j_pnpbp_2020_110148
S0278584620304644
Genre Research Support, Non-U.S. Gov't
Journal Article
Review
GroupedDBID ---
--K
--M
.~1
0R~
123
1B1
1RT
1~.
1~5
4.4
457
4G.
5RE
7-5
71M
8P~
9JM
AABNK
AACTN
AADPK
AAEDT
AAEDW
AAIAV
AAIKJ
AAKOC
AALRI
AAOAW
AATCM
AAXLA
AAXUO
ABCQJ
ABFRF
ABIVO
ABJNI
ABMAC
ABYKQ
ABZDS
ACDAQ
ACGFO
ACGFS
ACIUM
ACRLP
ADBBV
ADEZE
AEBSH
AEFWE
AEKER
AENEX
AFKWA
AFTJW
AFXIZ
AGHFR
AGUBO
AGWIK
AGYEJ
AIEXJ
AIKHN
AITUG
AJOXV
ALCLG
ALMA_UNASSIGNED_HOLDINGS
AMFUW
AMRAJ
AXJTR
BKOJK
BLXMC
C45
CS3
DU5
EBS
EFJIC
EFLBG
EO8
EO9
EP2
EP3
F5P
FDB
FIRID
FNPLU
FYGXN
G-Q
GBLVA
IHE
J1W
KOM
L7B
M2V
M34
M41
MO0
MOBAO
N9A
O-L
O9-
OAUVE
OGGZJ
OVD
OZT
P-8
P-9
P2P
PC.
Q38
ROL
RPZ
SCC
SDF
SDG
SES
SSN
SSP
SSZ
T5K
TEORI
~G-
.GJ
29P
53G
5VS
AAQFI
AAQXK
AATTM
AAXKI
AAYWO
AAYXX
ABWVN
ABXDB
ACRPL
ACVFH
ADCNI
ADMUD
ADNMO
AEIPS
AEUPX
AFJKZ
AFPUW
AGCQF
AGQPQ
AGRNS
AHHHB
AIGII
AIIUN
AKBMS
AKRWK
AKYEP
ANKPU
APXCP
ASPBG
AVWKF
AZFZN
BNPGV
CITATION
EJD
FEDTE
FGOYB
G-2
HMQ
HMT
HVGLF
HZ~
R2-
RIG
SEW
SNS
SPT
SSH
WUQ
ZGI
CGR
CUY
CVF
ECM
EFKBS
EIF
NPM
7X8
ID FETCH-LOGICAL-c404t-2e347b2c2d1bff8880e6bca01de492bb830c7b98900d333fb7b0f2ca7704bc73
IEDL.DBID AIKHN
ISSN 0278-5846
1878-4216
IngestDate Fri Sep 05 11:37:43 EDT 2025
Mon Jul 21 06:02:23 EDT 2025
Tue Jul 01 01:50:26 EDT 2025
Thu Apr 24 23:08:09 EDT 2025
Fri Feb 23 02:38:59 EST 2024
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Keywords Neuroimaging
fMRI
Neurology
Neuroscience
Interventions
sMRI
Neurocognition
Heroin
Language English
License Copyright © 2020 Elsevier Inc. All rights reserved.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c404t-2e347b2c2d1bff8880e6bca01de492bb830c7b98900d333fb7b0f2ca7704bc73
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
ObjectType-Review-3
content type line 23
OpenAccessLink https://www.sciencedirect.com/science/article/pii/S0278584620304644
PMID 33169674
PQID 2459349491
PQPubID 23479
ParticipantIDs proquest_miscellaneous_2459349491
pubmed_primary_33169674
crossref_primary_10_1016_j_pnpbp_2020_110148
crossref_citationtrail_10_1016_j_pnpbp_2020_110148
elsevier_sciencedirect_doi_10_1016_j_pnpbp_2020_110148
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2021-12-20
PublicationDateYYYYMMDD 2021-12-20
PublicationDate_xml – month: 12
  year: 2021
  text: 2021-12-20
  day: 20
PublicationDecade 2020
PublicationPlace England
PublicationPlace_xml – name: England
PublicationTitle Progress in neuro-psychopharmacology & biological psychiatry
PublicationTitleAlternate Prog Neuropsychopharmacol Biol Psychiatry
PublicationYear 2021
Publisher Elsevier Inc
Publisher_xml – name: Elsevier Inc
References Data Overview, Drug Overdose, CDC Injury Center (bb0080) 2020
Achamallah, Wright, Fried (bb0005) 2019; 20
Ateş Çöl, Sönmez, Vardar (bb0030) 2016; 53
Christie (bb0070) 2008
Apodaca, Longabaugh (bb0020) 2009
Baldacchino, Balfour, Matthews (bb0040) 2015; 45
Hasin, Nunes, Meydan, Nunes, Meydan (bb0130) 2004
Shen, Cao, Tan, Shan, Wang, Pan, He, Yuan (bb0315) 2016
Denier, Schmidt, Gerber, Schmid, Riecher-Rössler, Wiesbeck, Huber, Lang, Radue, Walter, Borgwardt (bb0090) 2013; 4
Wang, Li, Zhou, Liao, Tang, Liu, Hu, Hao (bb0415) 2012; 126
McNairy, Maruta, Ivnik, Swanson, Ilstrup (bb1000) 1984; 18
Rezapour, Hatami, Farhoudian, Sofuoglu, Noroozi, Daneshmand, Samiei, Ekhtiari (bb0290) 2019; 29
Philips, Ford, Bonnie (bb0270) 2017
Verdejo-García, Pérez-García (bb0370) 2007; 190
Ekhtiari, Rezapour, Aupperle, Paulus (bb8000) 2017
Risdahl, Khanna, Peterson, Molitor (bb0295) 1998; 83
Goldstein, Volkow (bb0120) 2011; 12
Oei, Lim, Young (bb0255) 1991; 10
Ersche, Roiser, Clark, London, Robbins, Sahakian (bb3000) 2005; 30
Fields, Margolis (bb0110) 2015
American Psychiatric Association (bb0010) 2013
Pirastu, Fais, Messina, Bini, Spiga, Falconieri, Diana (bb0275) 2006; 83
Liu, Hao, Kaneko, Ouyang, Zhang, Xu, Xue, Liu (bb0225) 2009; 63
World Health Organization (bb0145) 2020
Radke, Owen, Sutter, Ford, Albertson (bb0280) 2014
Castine, Albein-Urios, Lozano-Rojas, Martinez-Gonzalez, Hohwy, Verdejo-Garcia (bb0065) 2019; 45
Luigjes, Segrave, de Joode, Figee, Denys (bb0230) 2019
Rudd, Seth, David, Scholl (bb0300) 2016; 65
Tolomeo, Gray, Matthews, Steele, Baldacchino (bb0340) 2016; 46
Zijlstra, Booij, van den Brink, Franken (bb0440) 2008; 18
MacLean, Sofuoglu, Brede, Robinson, Waters (bb9000) 2018
World Drug Report (bb0425) 2019
Hassan, Al Jawad, Alsaihati, Alaithan, Al Hawaj (bb0140) 2019; 2
Kish, Kalasinsky, Derkach, Schmunk, Guttman, Ang, Adams, Furukawa, Haycock (bb0160) 2001; 24
Langleben, Ruparel, Elman, Busch-Winokur, Pratiwadi, Loughead, O’Brien, Childress (bb0200) 2008; 165
Wang, Li, Wang, Tian, Yang, Li, Qin, Yuan, Liu (bb0410) 2011; 37
Kieffer, Evans (bb0155) 2002; 108
Lin, Liu, Li, Yu, Shen, Lou, Xie, Chen, Zhang, Yuan (bb0220) 2019; 58
Andersen, Skullerud (bb0015) 1999; 102
Larochelle, Bernson, Land, Stopka, Wang, Xuan, Bagley, Liebschutz, Walley (bb0210) 2018
Larimer, Palmer, Alan Marlatt (bb0205) 2003
Yuan, Zhu, Shi, Zou, Yuan, Liu, Lee, Weng (bb0430) 2009; 71
Gradin, Baldacchino, Balfour, Matthews, Steele (bb0125) 2014; 39
Volkow, Fowler, Wang (bb0395) 2002; 13
Zacny (bb0435) 1995; 3
Jensen, Olsen, Winther (bb5000) 2009; 81
Wang, Volkow, Fowler, Logan, Abumrad, Hitzemann, Pappas, Pascani (bb0400) 1997; 16
Verdejo-García, Perales, Pérez-García (bb0380) 2007; 32
Oxberry, Bland, Clark, Cleland, Johnson (bb0260) 2013; 16
Mintzer, Copersino, Stitzer (bb0245) 2005; 78
Rezapour, DeVito, Sofuoglu, Ekhtiari (bb0285) 2016
Tolomeo, Davey, Steele, Baldacchino (bb0350) 2019; 10
Dehghani-Arani, Rostami, Nadali (bb0085) 2013; 38
Tolomeo, McFarlane, Baldacchino, Koob, Steele (bb1100) 2020
Volkow (bb0390) 2018
Ekhtiari, Tavakoli, Addolorato, Baeken, Bonci, Campanella, Castelo-Branco, Challet-Bouju, Clark, Claus, Dannon, Del Felice, den Uyl, Diana, di Giannantonio, Fedota, Fitzgerald, Gallimberti, Grall-Bronnec, Herremans, Herrmann, Jamil, Khedr, Kouimtsidis, Kozak, Krupitsky, Lamm, Lechner, Madeo, Malmir, Martinotti, McDonald, Montemitro, Nakamura-Palacios, Nasehi, Noël, Nosratabadi, Paulus, Pettorruso, Pradhan, Praharaj, Rafferty, Sahlem, Salmeron, Sauvaget, Schluter, Sergiou, Shahbabaie, Sheffer, Spagnolo, Steele, Yuan, van Dongen, Van Waes, Venkatasubramanian, Verdejo-García, Verveer, Welsh, Wesley, Witkiewitz, Yavari, Zarrindast, Zawertailo, Zhang, Cha, George, Frohlich, Goudriaan, Fecteau, Daughters, Stein, Fregni, Nitsche, Zangen, Bikson, Hanlon (bb0095) 2019
Brust (bb4000) 1997; 15
Moeller, Goldstein (bb0250) 2014
Verdejo-Garcia, Lorenzetti, Manning, Piercy, Bruno, Hester, Pennington, Tolomeo, Arunogiri, Bates, Bowden-Jones, Campanella, Daughters, Kouimtsidis, Lubman, Meyerhoff, Ralph, Rezapour, Tavakoli, Zare-Bidoky, Zilverstand, Steele, Moeller, Paulus, Baldacchino, Ekhtiari (bb0385) 2019
Baldacchino, Steele, Davey, Tolomeo (bb0045) 2019; 35
Commission on Narcotic Drugs opens its 57th session in Vienna (bb0075) 2020
Jamison, Schein, Vallow, Ascher, Vorsanger, Katz (bb0150) 2003; 26
Koob, Schulkin (bb0175) 2018
Kovacs, Horvath, Majtenyi, Lutz, Hurd, Keller (bb0190) 2015; 36
Kleber (bb0165) 2007; 9
Wang, Shen, Cao, Shan, Pan, He, Ma, Yuan (bb0420) 2016; 79
Tabatabaei-Jafari, Ekhtiari, Ganjgahi, Hassani-Abharian, Oghabian, Moradi, Sadighi, Zarei (bb0330) 2014; 8
Arani, Rostami, Nostratabadi (bb0025) 2010; 41
Trescot, Datta, Lee, Hans (bb0360) 2008
Tolomeo, Matthews, Steele, Baldacchino (bb0345) 2018; 81
Baldacchino (bb2200) 2019; 49
Beck (bb0055) 1979
Kreek, Reed, Butelman (bb0195) 2019; 5
Kovacs, Horvath, Majtenyi, Lutz, Hurd, Keller (bb0185) 2015; 36
Pearson, Baden, Richter (bb0265) 1976; 1
Rezapour, Barzegari, Sharifi, Malmir, Ghiasvand, Salehi, Noroozi, Ekhtiari (bb7000) 2020
Stewart, May, Aupperle, Bodurka (bb0320) 2019
Ersche, Fletcher, Roiser, Fryer, London, Robbins, Sahakian (bb0105) 2006; 188
Lyoo, Pollack, Silveri, Ahn, Diaz, Hwang, Kim, Yurgelun-Todd, Kaufman, Renshaw (bb0240) 2006; 184
Suh, Ressler (bb0325) 2018; 39
Verdejo-García, Bechara, Recknor, Pérez-García (bb0375) 2007; 91
Hassan, Howe, Samokhvalov, Le Foll, George (bb0135) 2017
Wang, Volkow, Fowler, Logan, Abumrad, Hitzemann, Pappas, Pascani (bb0405) 1997; 16
Ersche, Sahakian (bb0100) 2007
Stevens, Peschk, Schwarz (bb2000) 2007; 102
Lyoo, Streeter, Ahn, Lee, Pollack, Silveri, Nassar, Levin, Sarid-Segal, Ciraulo, Renshaw, Kaufman (bb0235) 2004; 131
Forman, Dougherty, Casey, Siegle, Braver, Barch, Stenger, Wick-Hull, Pisarov, Lorensen (bb0115) 2004; 55
Baldacchino, Balfour, Passetti, Humphris, Matthews (bb0035) 2012; 36
ROBLEMUNGASS (bb0365) 2016
Koob, Volkow (bb0180) 2016; 3
Taremian, Nazari, Moradveisi, Moloodi (bb0335) 2019; 35
Koob (10.1016/j.pnpbp.2020.110148_bb0175) 2018
Oei (10.1016/j.pnpbp.2020.110148_bb0255) 1991; 10
Hassan (10.1016/j.pnpbp.2020.110148_bb0140) 2019; 2
Rudd (10.1016/j.pnpbp.2020.110148_bb0300) 2016; 65
Zijlstra (10.1016/j.pnpbp.2020.110148_bb0440) 2008; 18
Liu (10.1016/j.pnpbp.2020.110148_bb0225) 2009; 63
Baldacchino (10.1016/j.pnpbp.2020.110148_bb0045) 2019; 35
Hassan (10.1016/j.pnpbp.2020.110148_bb0135) 2017
Denier (10.1016/j.pnpbp.2020.110148_bb0090) 2013; 4
Kieffer (10.1016/j.pnpbp.2020.110148_bb0155) 2002; 108
Rezapour (10.1016/j.pnpbp.2020.110148_bb0290) 2019; 29
Arani (10.1016/j.pnpbp.2020.110148_bb0025) 2010; 41
Lin (10.1016/j.pnpbp.2020.110148_bb0220) 2019; 58
Kish (10.1016/j.pnpbp.2020.110148_bb0160) 2001; 24
Stevens (10.1016/j.pnpbp.2020.110148_bb2000) 2007; 102
Wang (10.1016/j.pnpbp.2020.110148_bb0400) 1997; 16
Larochelle (10.1016/j.pnpbp.2020.110148_bb0210) 2018
Radke (10.1016/j.pnpbp.2020.110148_bb0280) 2014
Stewart (10.1016/j.pnpbp.2020.110148_bb0320) 2019
Taremian (10.1016/j.pnpbp.2020.110148_bb0335) 2019; 35
Verdejo-García (10.1016/j.pnpbp.2020.110148_bb0370) 2007; 190
Shen (10.1016/j.pnpbp.2020.110148_bb0315) 2016
Jamison (10.1016/j.pnpbp.2020.110148_bb0150) 2003; 26
Langleben (10.1016/j.pnpbp.2020.110148_bb0200) 2008; 165
Moeller (10.1016/j.pnpbp.2020.110148_bb0250) 2014
Brust (10.1016/j.pnpbp.2020.110148_bb4000) 1997; 15
Apodaca (10.1016/j.pnpbp.2020.110148_bb0020) 2009
Castine (10.1016/j.pnpbp.2020.110148_bb0065) 2019; 45
Ersche (10.1016/j.pnpbp.2020.110148_bb3000) 2005; 30
Ekhtiari (10.1016/j.pnpbp.2020.110148_bb8000) 2017
Beck (10.1016/j.pnpbp.2020.110148_bb0055) 1979
Commission on Narcotic Drugs opens its 57th session in Vienna (10.1016/j.pnpbp.2020.110148_bb0075)
Rezapour (10.1016/j.pnpbp.2020.110148_bb0285) 2016
Christie (10.1016/j.pnpbp.2020.110148_bb0070) 2008
Mintzer (10.1016/j.pnpbp.2020.110148_bb0245) 2005; 78
Koob (10.1016/j.pnpbp.2020.110148_bb0180) 2016; 3
Volkow (10.1016/j.pnpbp.2020.110148_bb0395) 2002; 13
Yuan (10.1016/j.pnpbp.2020.110148_bb0430) 2009; 71
Forman (10.1016/j.pnpbp.2020.110148_bb0115) 2004; 55
Trescot (10.1016/j.pnpbp.2020.110148_bb0360) 2008
Luigjes (10.1016/j.pnpbp.2020.110148_bb0230) 2019
Wang (10.1016/j.pnpbp.2020.110148_bb0405) 1997; 16
Hasin (10.1016/j.pnpbp.2020.110148_bb0130) 2004
Kleber (10.1016/j.pnpbp.2020.110148_bb0165) 2007; 9
Ateş Çöl (10.1016/j.pnpbp.2020.110148_bb0030) 2016; 53
Larimer (10.1016/j.pnpbp.2020.110148_bb0205) 2003
American Psychiatric Association (10.1016/j.pnpbp.2020.110148_bb0010) 2013
Ersche (10.1016/j.pnpbp.2020.110148_bb0100) 2007
Suh (10.1016/j.pnpbp.2020.110148_bb0325) 2018; 39
Lyoo (10.1016/j.pnpbp.2020.110148_bb0235) 2004; 131
Tolomeo (10.1016/j.pnpbp.2020.110148_bb0340) 2016; 46
Gradin (10.1016/j.pnpbp.2020.110148_bb0125) 2014; 39
Tabatabaei-Jafari (10.1016/j.pnpbp.2020.110148_bb0330) 2014; 8
Achamallah (10.1016/j.pnpbp.2020.110148_bb0005) 2019; 20
Ersche (10.1016/j.pnpbp.2020.110148_bb0105) 2006; 188
Oxberry (10.1016/j.pnpbp.2020.110148_bb0260) 2013; 16
MacLean (10.1016/j.pnpbp.2020.110148_bb9000) 2018
Jensen (10.1016/j.pnpbp.2020.110148_bb5000) 2009; 81
Data Overview, Drug Overdose, CDC Injury Center (10.1016/j.pnpbp.2020.110148_bb0080)
Kreek (10.1016/j.pnpbp.2020.110148_bb0195) 2019; 5
Kovacs (10.1016/j.pnpbp.2020.110148_bb0190) 2015; 36
Wang (10.1016/j.pnpbp.2020.110148_bb0410) 2011; 37
Baldacchino (10.1016/j.pnpbp.2020.110148_bb0035) 2012; 36
Volkow (10.1016/j.pnpbp.2020.110148_bb0390) 2018
World Health Organization (10.1016/j.pnpbp.2020.110148_bb0145) 2020
Tolomeo (10.1016/j.pnpbp.2020.110148_bb0350) 2019; 10
McNairy (10.1016/j.pnpbp.2020.110148_bb1000) 1984; 18
Zacny (10.1016/j.pnpbp.2020.110148_bb0435) 1995; 3
Ekhtiari (10.1016/j.pnpbp.2020.110148_bb0095) 2019
Pirastu (10.1016/j.pnpbp.2020.110148_bb0275) 2006; 83
Verdejo-García (10.1016/j.pnpbp.2020.110148_bb0380) 2007; 32
Rezapour (10.1016/j.pnpbp.2020.110148_bb7000) 2020
World Drug Report (10.1016/j.pnpbp.2020.110148_bb0425)
Tolomeo (10.1016/j.pnpbp.2020.110148_bb1100) 2020
Fields (10.1016/j.pnpbp.2020.110148_bb0110) 2015
Risdahl (10.1016/j.pnpbp.2020.110148_bb0295) 1998; 83
Dehghani-Arani (10.1016/j.pnpbp.2020.110148_bb0085) 2013; 38
Kovacs (10.1016/j.pnpbp.2020.110148_bb0185) 2015; 36
ROBLEMUNGASS (10.1016/j.pnpbp.2020.110148_bb0365) 2016
Goldstein (10.1016/j.pnpbp.2020.110148_bb0120) 2011; 12
Philips (10.1016/j.pnpbp.2020.110148_bb0270) 2017
Verdejo-Garcia (10.1016/j.pnpbp.2020.110148_bb0385) 2019
Wang (10.1016/j.pnpbp.2020.110148_bb0420) 2016; 79
Pearson (10.1016/j.pnpbp.2020.110148_bb0265) 1976; 1
Andersen (10.1016/j.pnpbp.2020.110148_bb0015) 1999; 102
Lyoo (10.1016/j.pnpbp.2020.110148_bb0240) 2006; 184
Tolomeo (10.1016/j.pnpbp.2020.110148_bb0345) 2018; 81
Verdejo-García (10.1016/j.pnpbp.2020.110148_bb0375) 2007; 91
Wang (10.1016/j.pnpbp.2020.110148_bb0415) 2012; 126
Baldacchino (10.1016/j.pnpbp.2020.110148_bb0040) 2015; 45
Baldacchino (10.1016/j.pnpbp.2020.110148_bb2200) 2019; 49
References_xml – volume: 41
  start-page: 170
  year: 2010
  end-page: 177
  ident: bb0025
  article-title: Effectiveness of neurofeedback training as a treatment for opioid-dependent patients
  publication-title: Clin. EEG Neurosci.
– volume: 184
  start-page: 139
  year: 2006
  end-page: 144
  ident: bb0240
  article-title: Prefrontal and temporal gray matter density decreases in opiate dependence
  publication-title: Psychopharmacology
– volume: 29
  start-page: 1273
  year: 2019
  end-page: 1289
  ident: bb0290
  article-title: Cognitive rehabilitation for individuals with opioid use disorder: a randomized controlled trial*
  publication-title: Neuropsychol. Rehabil.
– volume: 32
  start-page: 950
  year: 2007
  end-page: 966
  ident: bb0380
  article-title: Cognitive impulsivity in cocaine and heroin polysubstance abusers
  publication-title: Addict. Behav.
– start-page: 12
  year: 2004
  end-page: 42
  ident: bb0130
  article-title: Comorbidity of alcohol
  publication-title: Drug Psychiatr. Disord.
– year: 2017
  ident: bb0135
  article-title: Management of mood and anxiety disorders in patients receiving opioid agonist therapy: review and meta-analysis
  publication-title: Am. J. Addict.
– volume: 190
  start-page: 517
  year: 2007
  end-page: 530
  ident: bb0370
  article-title: Profile of executive deficits in cocaine and heroin polysubstance users: common and differential effects on separate executive components
  publication-title: Psychopharmacology
– volume: 102
  start-page: 51
  year: 1999
  end-page: 59
  ident: bb0015
  article-title: Hypoxic/ischaemic brain damage, especially pallidal lesions, in heroin addicts
  publication-title: Forensic Sci. Int.
– year: 2020
  ident: bb0145
  article-title: International standards for the treatment of drug use disorders: revised edition incorporating results of field-testing
– volume: 37
  start-page: 123
  year: 2011
  end-page: 130
  ident: bb0410
  article-title: Brain fMRI and craving response to heroin-related cues in patients on methadone maintenance treatment
  publication-title: Am. J. Drug Alcohol Abuse
– year: 2018
  ident: bb0175
  article-title: Addiction and stress: an allostatic view
  publication-title: Neurosci. Biobehav. Rev.
– volume: 39
  start-page: 885
  year: 2014
  end-page: 894
  ident: bb0125
  article-title: Abnormal brain activity during a reward and loss task in opiate-dependent patients receiving methadone maintenance therapy
  publication-title: Neuropsychopharmacology
– year: 2014
  ident: bb0250
  article-title: Impaired self-awareness in human addiction: deficient attribution of personal relevance
  publication-title: Trends Cogn. Sci.
– volume: 81
  start-page: 354
  year: 2009
  end-page: 357
  ident: bb5000
  article-title: Severe non-occlusive ischemic stroke in young heroin addicts
  publication-title: Acta Neurol. Scand.
– volume: 108
  start-page: 587
  year: 2002
  end-page: 590
  ident: bb0155
  article-title: Opioid tolerance-in search of the holy grail
  publication-title: Cell
– year: 2020
  ident: bb7000
  article-title: Neuroscience-Informed Psychoeducation for Recovery (NIPER): A Program to Promote Metacognition in People with Substance Use Disorders
– volume: 20
  start-page: 80
  year: 2019
  end-page: 85
  ident: bb0005
  article-title: Chasing the wrong dragon: a new presentation of heroin-induced toxic leukoencephalopathy mimicking anoxic brain injury
  publication-title: J. Intensiv. Care Soc.
– year: 2018
  ident: bb9000
  article-title: Attentional bias in opioid users: A systematic review and meta-analysis
  publication-title: Drug Alcohol Depend
– volume: 9
  start-page: 455
  year: 2007
  ident: bb0165
  article-title: Pharmacologic treatments for opioid dependence: detoxification and maintenance options
  publication-title: Dialogues Clin. Neurosci.
– volume: 91
  start-page: 213
  year: 2007
  end-page: 219
  ident: bb0375
  article-title: Negative emotion-driven impulsivity predicts substance dependence problems
  publication-title: Drug Alcohol Depend.
– year: 2016
  ident: bb0315
  article-title: 10-Hz repetitive transcranial magnetic stimulation of the left dorsolateral prefrontal cortex reduces heroin Cue craving in long-term addicts
  publication-title: Biol. Psychiatry
– volume: 26
  start-page: 913
  year: 2003
  end-page: 921
  ident: bb0150
  article-title: Neuropsychological effects of long-term opioid use in chronic pain patients
  publication-title: J. Pain Symptom Manag.
– volume: 165
  start-page: 390
  year: 2008
  end-page: 394
  ident: bb0200
  article-title: Acute effect of methadone maintenance dose on brain fMRI response to heroin-related cues
  publication-title: Am. J. Psychiatry
– start-page: 345
  year: 2016
  end-page: 369
  ident: bb0285
  article-title: Perspectives on neurocognitive rehabilitation as an adjunct treatment for addictive disorders: from cognitive improvement to relapse prevention
  publication-title: Progress in Brain Research
– start-page: 1
  year: 2003
  end-page: 17
  ident: bb0205
  article-title: Relapse prevention an overview of Marlatt’s cognitive-behavioral model
  publication-title: Psychosocial Treatments
– year: 2018
  ident: bb0210
  article-title: Medication for Opioid use Disorder After Nonfatal Opioid Overdose and Association with Mortality A Cohort Study
– volume: 53
  start-page: 15
  year: 2016
  end-page: 20
  ident: bb0030
  article-title: Evaluation of interoceptive awareness in alcohol-addicted patients
  publication-title: Noropsikiyatri Ars.
– volume: 49
  start-page: 1174
  year: 2019
  end-page: 1184
  ident: bb2200
  article-title: Profiles of visuospatial memory dysfunction in opioid-exposed and dependent populations
  publication-title: Psychol. Med.
– volume: 131
  start-page: 135
  year: 2004
  end-page: 145
  ident: bb0235
  article-title: White matter hyperintensities in subjects with cocaine and opiate dependence and healthy comparison subjects
  publication-title: Psychiatry Res.
– volume: 30
  start-page: 2115
  year: 2005
  end-page: 2124
  ident: bb3000
  article-title: Punishment induces risky decision-making in methadone-maintained opiate users but not in heroin users or healthy volunteers
  publication-title: Neuropsychopharmacology
– year: 1979
  ident: bb0055
  article-title: Cognitive Theory of Depression
– year: 2020
  ident: bb0080
  article-title: WWW Document
– year: 2015
  ident: bb0110
  article-title: Understanding opioid reward
  publication-title: Trends Neurosci.
– volume: 58
  start-page: 7
  year: 2019
  end-page: 12
  ident: bb0220
  article-title: Chronic repetitive transcranial magnetic stimulation (rTMS)on sleeping quality and mood status in drug dependent male inpatients during abstinence
  publication-title: Sleep Med.
– volume: 16
  start-page: 250
  year: 2013
  end-page: 255
  ident: bb0260
  article-title: Repeat dose opioids May be effective for breathlessness in chronic heart failure if given for long enough
  publication-title: J. Palliat. Med.
– year: 2008
  ident: bb0070
  article-title: Cellular neuroadaptations to chronic opioids: tolerance, withdrawal and addiction
  publication-title: Br. J. Pharmacol.
– volume: 10
  start-page: 63
  year: 1991
  end-page: 80
  ident: bb0255
  article-title: Cognitive processes and cognititve behavior therapy in the treatment of problem drinking
  publication-title: J. Addict. Dis.
– volume: 83
  start-page: 4
  year: 1998
  end-page: 18
  ident: bb0295
  article-title: Opiates and infection
  publication-title: J. Neuroimmunol.
– volume: 3
  start-page: 432
  year: 1995
  end-page: 466
  ident: bb0435
  article-title: A review of the effects of opioids on psychomotor and cognitive functioning in humans
  publication-title: Exp. Clin. Psychopharmacol.
– year: 2019
  ident: bb0230
  article-title: Efficacy of invasive and non-invasive brain modulation interventions for addiction
  publication-title: Neuropsychol. Rev.
– year: 2019
  ident: bb0320
  article-title: Forging neuroimaging targets for recovery in opioid use disorder
  publication-title: Front. Psychiatry.
– volume: 4
  year: 2013
  ident: bb0090
  article-title: Association of frontal gray matter volume and cerebral perfusion in heroin addiction: a multimodal neuroimaging study
  publication-title: Front. Psychiatry
– start-page: 239
  year: 2017
  end-page: 264
  ident: bb8000
  article-title: Neuroscience-informed psychoeducation for addiction medicine: A neurocognitive perspective
  publication-title: Progress in Brain Research
– volume: 18
  start-page: 262
  year: 2008
  end-page: 270
  ident: bb0440
  article-title: Striatal dopamine D2 receptor binding and dopamine release during cue-elicited craving in recently abstinent opiate-dependent males
  publication-title: Eur. Neuropsychopharmacol.
– volume: 102
  start-page: 937
  year: 2007
  end-page: 946
  ident: bb2000
  article-title: Implicit learning, executive function and hedonic activity in chronic polydrug abusers, currently abstinent polydrug abusers and controls
  publication-title: Addiction
– volume: 10
  year: 2019
  ident: bb0350
  article-title: Effects of opioid dependence on visuospatial memory and its associations with depression and anxiety
  publication-title: Front. Psychiatry
– volume: 45
  start-page: 108
  year: 2019
  end-page: 114
  ident: bb0065
  article-title: Self-awareness deficits associated with lower treatment motivation in cocaine addiction
  publication-title: Am. J. Drug Alcohol Abuse
– volume: 2
  start-page: 62
  year: 2019
  end-page: 68
  ident: bb0140
  article-title: Bilateral basal ganglia lesions in patients with heroin overdose: A report of two cases
  publication-title: Case Rep. Acute Med.
– volume: 46
  start-page: 2841
  year: 2016
  end-page: 2853
  ident: bb0340
  article-title: Multifaceted impairments in impulsivity and brain structural abnormalities in opioid dependence and abstinence
  publication-title: Psychol. Med.
– volume: 81
  year: 2018
  ident: bb0345
  article-title: Compulsivity in opioid dependence
  publication-title: Prog. Neuro-Psychopharmacol. Biol. Psychiatr.
– volume: 126
  start-page: 304
  year: 2012
  end-page: 308
  ident: bb0415
  article-title: Changes in brain gray matter in abstinent heroin addicts
  publication-title: Drug Alcohol Depend.
– volume: 63
  start-page: 563
  year: 2009
  end-page: 568
  ident: bb0225
  article-title: Frontal and cingulate gray matter volume reduction in heroin dependence: optimized voxel-based morphometry
  publication-title: Psychiatry Clin. Neurosci.
– year: 2019
  ident: bb0385
  article-title: A roadmap for integrating neuroscience into addiction treatmmeent: a consensus of the neuroscience Interest group of the international society of addiction medicine
  publication-title: Front. Psychiatry.
– volume: 38
  start-page: 133
  year: 2013
  end-page: 141
  ident: bb0085
  article-title: Neurofeedback training for opiate addiction: improvement of mental health and craving
  publication-title: Appl. Psychophysiol. Biofeedback
– year: 2020
  ident: bb0075
  article-title: WWW Document
– volume: 55
  start-page: 531
  year: 2004
  end-page: 537
  ident: bb0115
  article-title: Opiate addicts lack error-dependent activation of rostral anterior cingulate
  publication-title: Biol. Psychiatry
– volume: 35
  start-page: 201
  year: 2019
  end-page: 206
  ident: bb0335
  article-title: Transcranial direct current stimulation on opium craving, depression, and anxiety: a preliminary study
  publication-title: J. ECT
– volume: 71
  start-page: 223
  year: 2009
  end-page: 228
  ident: bb0430
  article-title: Gray matter density negatively correlates with duration of heroin use in young lifetime heroin-dependent individuals
  publication-title: Brain Cogn.
– year: 2009
  ident: bb0020
  article-title: Mechanisms of change in motivational interviewing: a review and preliminary evaluation of the evidence
  publication-title: Addiction.
– volume: 15
  start-page: 945
  year: 1997
  end-page: 957
  ident: bb4000
  article-title: Vasculitis owing to substance abuse
  publication-title: Neurol. Clin.
– year: 2019
  ident: bb0425
  article-title: WWW Document
– volume: 36
  start-page: 3100
  year: 2015
  end-page: 3107
  ident: bb0185
  article-title: Heroin abuse exaggerates age-related deposition of hyperphosphorylated tau and p62-positive inclusions
  publication-title: Neurobiol. Aging
– volume: 13
  start-page: 355
  year: 2002
  end-page: 366
  ident: bb0395
  article-title: Role of dopamine in drug reinforcement and addiction in humans: results from imaging studies
  publication-title: Behav. Pharmacol.
– volume: 3
  start-page: 760
  year: 2016
  end-page: 773
  ident: bb0180
  article-title: Neurobiology of addiction: a neurocircuitry analysis
  publication-title: Lancet Psychiatry
– year: 2007
  ident: bb0100
  article-title: The neuropsychology of amphetamine and opiate dependence: implications for treatment
  publication-title: Neuropsychol. Rev.
– volume: 16
  start-page: 174
  year: 1997
  end-page: 182
  ident: bb0400
  article-title: Dopamine D2 receptor availability in opiate-dependent subjects before and after naloxone-precipitated withdrawal
  publication-title: Neuropsychopharmacology
– volume: 45
  start-page: 1167
  year: 2015
  end-page: 1179
  ident: bb0040
  article-title: Impulsivity and opioid drugs: differential effects of heroin, methadone and prescribed analgesic medication
  publication-title: Psychol. Med.
– year: 2017
  ident: bb0270
  article-title: Pain Management and the Opioid Epidemic, Pain Management and the Opioid Epidemic
– volume: 36
  start-page: 3100
  year: 2015
  end-page: 3107
  ident: bb0190
  article-title: Heroin abuse exaggerates age-related deposition of hyperphosphorylated tau and p62-positive inclusions
  publication-title: Neurobiol. Aging
– volume: 79
  start-page: 1
  year: 2016
  end-page: 3
  ident: bb0420
  article-title: Transcranial direct current stimulation of the frontal-parietal-temporal area attenuates cue-induced craving for heroin
  publication-title: J. Psychiatr. Res.
– year: 2008
  ident: bb0360
  article-title: Opioid pharmacology
  publication-title: Pain Physician.
– year: 2018
  ident: bb0390
  article-title: Medications for opioid use disorder: bridging the gap in care
  publication-title: Lancet.
– volume: 8
  start-page: 123
  year: 2014
  end-page: 129
  ident: bb0330
  article-title: Patterns of brain activation during craving in heroin dependents successfully treated by methadone maintenance and abstinence-based treatments
  publication-title: J. Addict. Med.
– volume: 35
  start-page: 179
  year: 2019
  end-page: 198
  ident: bb0045
  article-title: Cognitive consequences of opioid use
  publication-title: Cogn. Addict. A Res. Guid. Mech. Towar. Interv.
– year: 2013
  ident: bb0010
  article-title: DSM-V
– volume: 24
  start-page: 561
  year: 2001
  end-page: 567
  ident: bb0160
  article-title: Striatal dopaminergic and serotonergic markers in human heroin users
  publication-title: Neuropsychopharmacology
– volume: 12
  start-page: 652
  year: 2011
  end-page: 669
  ident: bb0120
  article-title: Dysfunction of the prefrontal cortex in addiction: neuroimaging findings and clinical implications
  publication-title: Nat. Rev. Neurosci.
– volume: 16
  start-page: 174
  year: 1997
  end-page: 182
  ident: bb0405
  article-title: Dopamine D2 receptor availability in opiate-dependent subjects before and after naloxone-precipitated withdrawal
  publication-title: Neuropsychopharmacology
– volume: 78
  start-page: 225
  year: 2005
  end-page: 230
  ident: bb0245
  article-title: Opioid abuse and cognitive performance
  publication-title: Drug Alcohol Depend.
– volume: 83
  start-page: 163
  year: 2006
  end-page: 168
  ident: bb0275
  article-title: Impaired decision-making in opiate-dependent subjects: effect of pharmacological therapies
  publication-title: Drug Alcohol Depend.
– year: 2014
  ident: bb0280
  article-title: The effects of opioids on the lung
  publication-title: Clin. Rev. Allergy Immunol.
– year: 2020
  ident: bb1100
  article-title: Alcohol Binge Drinking: Negative and Positive Valence System Abnormalitier
  publication-title: Biol. Psychiatry
– volume: 5
  year: 2019
  ident: bb0195
  article-title: Current status of opioid addiction treatment and related preclinical research
  publication-title: Sci. Adv.
– year: 2019
  ident: bb0095
  article-title: Transcranial electrical and magnetic stimulation (tES and TMS) for addiction medicine: A consensus paper on the present state of the science and the road ahead
  publication-title: Neurosci. Biobehav. Rev.
– volume: 188
  start-page: 364
  year: 2006
  end-page: 373
  ident: bb0105
  article-title: Differences in orbitofrontal activation during decision-making between methadone-maintained opiate users, heroin users and healthy volunteers
  publication-title: Psychopharmacology
– year: 2016
  ident: bb0365
  article-title: Outcome document of the 2016 United Nations General Assembly Special Session on the World Drug Problem our Joint Commitment to Effectively Addressing and Countering the World Drug Problem, Special Session of the United Nations General Assembly on the World Drug Problem
– volume: 36
  start-page: 2056
  year: 2012
  end-page: 2068
  ident: bb0035
  article-title: Neuropsychological consequences of chronic opioid use: A quantitative review and meta-analysis
  publication-title: Neurosci. Biobehav. Rev.
– volume: 18
  start-page: 169
  year: 1984
  end-page: 177
  ident: bb1000
  article-title: Prescription medication dependence and neuropsychologic function
  publication-title: Pain
– volume: 1
  start-page: 349
  year: 1976
  end-page: 356
  ident: bb0265
  article-title: Neuronal depletion in the globus pallidus of heroin addicts
  publication-title: Drug Alcohol Depend.
– volume: 65
  start-page: 1445
  year: 2016
  end-page: 1452
  ident: bb0300
  article-title: Increases in drug and opioid-involved overdose deaths — United States, 2010-2015
  publication-title: Morb. Mortal. Wkly. Rep.
– volume: 39
  start-page: 131
  year: 2018
  ident: bb0325
  article-title: Common biological mechanisms of alcohol use disorder and post-traumatic stress disorder
  publication-title: Alcohol Res. Curr. Rev.
– volume: 9
  start-page: 455
  issue: 4
  year: 2007
  ident: 10.1016/j.pnpbp.2020.110148_bb0165
  article-title: Pharmacologic treatments for opioid dependence: detoxification and maintenance options
  publication-title: Dialogues Clin. Neurosci.
  doi: 10.31887/DCNS.2007.9.2/hkleber
– volume: 5
  year: 2019
  ident: 10.1016/j.pnpbp.2020.110148_bb0195
  article-title: Current status of opioid addiction treatment and related preclinical research
  publication-title: Sci. Adv.
  doi: 10.1126/sciadv.aax9140
– volume: 39
  start-page: 885
  year: 2014
  ident: 10.1016/j.pnpbp.2020.110148_bb0125
  article-title: Abnormal brain activity during a reward and loss task in opiate-dependent patients receiving methadone maintenance therapy
  publication-title: Neuropsychopharmacology
  doi: 10.1038/npp.2013.289
– volume: 36
  start-page: 3100
  year: 2015
  ident: 10.1016/j.pnpbp.2020.110148_bb0185
  article-title: Heroin abuse exaggerates age-related deposition of hyperphosphorylated tau and p62-positive inclusions
  publication-title: Neurobiol. Aging
  doi: 10.1016/j.neurobiolaging.2015.07.018
– volume: 10
  start-page: 63
  year: 1991
  ident: 10.1016/j.pnpbp.2020.110148_bb0255
  article-title: Cognitive processes and cognititve behavior therapy in the treatment of problem drinking
  publication-title: J. Addict. Dis.
  doi: 10.1300/J069v10n03_07
– volume: 79
  start-page: 1
  year: 2016
  ident: 10.1016/j.pnpbp.2020.110148_bb0420
  article-title: Transcranial direct current stimulation of the frontal-parietal-temporal area attenuates cue-induced craving for heroin
  publication-title: J. Psychiatr. Res.
  doi: 10.1016/j.jpsychires.2016.04.001
– volume: 78
  start-page: 225
  year: 2005
  ident: 10.1016/j.pnpbp.2020.110148_bb0245
  article-title: Opioid abuse and cognitive performance
  publication-title: Drug Alcohol Depend.
  doi: 10.1016/j.drugalcdep.2004.10.008
– year: 2008
  ident: 10.1016/j.pnpbp.2020.110148_bb0070
  article-title: Cellular neuroadaptations to chronic opioids: tolerance, withdrawal and addiction
  publication-title: Br. J. Pharmacol.
  doi: 10.1038/bjp.2008.100
– volume: 29
  start-page: 1273
  year: 2019
  ident: 10.1016/j.pnpbp.2020.110148_bb0290
  article-title: Cognitive rehabilitation for individuals with opioid use disorder: a randomized controlled trial*
  publication-title: Neuropsychol. Rehabil.
  doi: 10.1080/09602011.2017.1391103
– volume: 38
  start-page: 133
  year: 2013
  ident: 10.1016/j.pnpbp.2020.110148_bb0085
  article-title: Neurofeedback training for opiate addiction: improvement of mental health and craving
  publication-title: Appl. Psychophysiol. Biofeedback
  doi: 10.1007/s10484-013-9218-5
– volume: 55
  start-page: 531
  year: 2004
  ident: 10.1016/j.pnpbp.2020.110148_bb0115
  article-title: Opiate addicts lack error-dependent activation of rostral anterior cingulate
  publication-title: Biol. Psychiatry
  doi: 10.1016/j.biopsych.2003.09.011
– volume: 13
  start-page: 355
  year: 2002
  ident: 10.1016/j.pnpbp.2020.110148_bb0395
  article-title: Role of dopamine in drug reinforcement and addiction in humans: results from imaging studies
  publication-title: Behav. Pharmacol.
  doi: 10.1097/00008877-200209000-00008
– year: 2018
  ident: 10.1016/j.pnpbp.2020.110148_bb0390
  article-title: Medications for opioid use disorder: bridging the gap in care
  publication-title: Lancet.
  doi: 10.1016/S0140-6736(17)32893-3
– ident: 10.1016/j.pnpbp.2020.110148_bb0425
– volume: 53
  start-page: 15
  year: 2016
  ident: 10.1016/j.pnpbp.2020.110148_bb0030
  article-title: Evaluation of interoceptive awareness in alcohol-addicted patients
  publication-title: Noropsikiyatri Ars.
– volume: 58
  start-page: 7
  year: 2019
  ident: 10.1016/j.pnpbp.2020.110148_bb0220
  article-title: Chronic repetitive transcranial magnetic stimulation (rTMS)on sleeping quality and mood status in drug dependent male inpatients during abstinence
  publication-title: Sleep Med.
  doi: 10.1016/j.sleep.2019.01.052
– year: 2014
  ident: 10.1016/j.pnpbp.2020.110148_bb0280
  article-title: The effects of opioids on the lung
  publication-title: Clin. Rev. Allergy Immunol.
  doi: 10.1007/s12016-013-8373-z
– volume: 65
  start-page: 1445
  year: 2016
  ident: 10.1016/j.pnpbp.2020.110148_bb0300
  article-title: Increases in drug and opioid-involved overdose deaths — United States, 2010-2015
  publication-title: Morb. Mortal. Wkly. Rep.
  doi: 10.15585/mmwr.mm655051e1
– volume: 37
  start-page: 123
  year: 2011
  ident: 10.1016/j.pnpbp.2020.110148_bb0410
  article-title: Brain fMRI and craving response to heroin-related cues in patients on methadone maintenance treatment
  publication-title: Am. J. Drug Alcohol Abuse
  doi: 10.3109/00952990.2010.543997
– year: 2017
  ident: 10.1016/j.pnpbp.2020.110148_bb0270
– year: 2017
  ident: 10.1016/j.pnpbp.2020.110148_bb0135
  article-title: Management of mood and anxiety disorders in patients receiving opioid agonist therapy: review and meta-analysis
  publication-title: Am. J. Addict.
  doi: 10.1111/ajad.12581
– year: 2020
  ident: 10.1016/j.pnpbp.2020.110148_bb1100
  article-title: Alcohol Binge Drinking: Negative and Positive Valence System Abnormalitier
  publication-title: Biol. Psychiatry
– year: 2007
  ident: 10.1016/j.pnpbp.2020.110148_bb0100
  article-title: The neuropsychology of amphetamine and opiate dependence: implications for treatment
  publication-title: Neuropsychol. Rev.
  doi: 10.1007/s11065-007-9033-y
– volume: 2
  start-page: 62
  year: 2019
  ident: 10.1016/j.pnpbp.2020.110148_bb0140
  article-title: Bilateral basal ganglia lesions in patients with heroin overdose: A report of two cases
  publication-title: Case Rep. Acute Med.
  doi: 10.1159/000503952
– volume: 26
  start-page: 913
  year: 2003
  ident: 10.1016/j.pnpbp.2020.110148_bb0150
  article-title: Neuropsychological effects of long-term opioid use in chronic pain patients
  publication-title: J. Pain Symptom Manag.
  doi: 10.1016/S0885-3924(03)00310-5
– year: 2018
  ident: 10.1016/j.pnpbp.2020.110148_bb0175
  article-title: Addiction and stress: an allostatic view
  publication-title: Neurosci. Biobehav. Rev.
– year: 2020
  ident: 10.1016/j.pnpbp.2020.110148_bb7000
– volume: 126
  start-page: 304
  year: 2012
  ident: 10.1016/j.pnpbp.2020.110148_bb0415
  article-title: Changes in brain gray matter in abstinent heroin addicts
  publication-title: Drug Alcohol Depend.
  doi: 10.1016/j.drugalcdep.2012.05.030
– volume: 35
  start-page: 179
  year: 2019
  ident: 10.1016/j.pnpbp.2020.110148_bb0045
  article-title: Cognitive consequences of opioid use
  publication-title: Cogn. Addict. A Res. Guid. Mech. Towar. Interv.
– start-page: 345
  year: 2016
  ident: 10.1016/j.pnpbp.2020.110148_bb0285
  article-title: Perspectives on neurocognitive rehabilitation as an adjunct treatment for addictive disorders: from cognitive improvement to relapse prevention
  doi: 10.1016/bs.pbr.2015.07.022
– volume: 41
  start-page: 170
  year: 2010
  ident: 10.1016/j.pnpbp.2020.110148_bb0025
  article-title: Effectiveness of neurofeedback training as a treatment for opioid-dependent patients
  publication-title: Clin. EEG Neurosci.
  doi: 10.1177/155005941004100313
– volume: 91
  start-page: 213
  year: 2007
  ident: 10.1016/j.pnpbp.2020.110148_bb0375
  article-title: Negative emotion-driven impulsivity predicts substance dependence problems
  publication-title: Drug Alcohol Depend.
  doi: 10.1016/j.drugalcdep.2007.05.025
– year: 2016
  ident: 10.1016/j.pnpbp.2020.110148_bb0315
  article-title: 10-Hz repetitive transcranial magnetic stimulation of the left dorsolateral prefrontal cortex reduces heroin Cue craving in long-term addicts
  publication-title: Biol. Psychiatry
  doi: 10.1016/j.biopsych.2016.02.006
– ident: 10.1016/j.pnpbp.2020.110148_bb0080
– year: 2016
  ident: 10.1016/j.pnpbp.2020.110148_bb0365
– volume: 24
  start-page: 561
  year: 2001
  ident: 10.1016/j.pnpbp.2020.110148_bb0160
  article-title: Striatal dopaminergic and serotonergic markers in human heroin users
  publication-title: Neuropsychopharmacology
  doi: 10.1016/S0893-133X(00)00209-8
– year: 2018
  ident: 10.1016/j.pnpbp.2020.110148_bb9000
  article-title: Attentional bias in opioid users: A systematic review and meta-analysis
  publication-title: Drug Alcohol Depend
  doi: 10.1016/j.drugalcdep.2018.07.012
– volume: 16
  start-page: 174
  year: 1997
  ident: 10.1016/j.pnpbp.2020.110148_bb0405
  article-title: Dopamine D2 receptor availability in opiate-dependent subjects before and after naloxone-precipitated withdrawal
  publication-title: Neuropsychopharmacology
  doi: 10.1016/S0893-133X(96)00184-4
– volume: 18
  start-page: 169
  year: 1984
  ident: 10.1016/j.pnpbp.2020.110148_bb1000
  article-title: Prescription medication dependence and neuropsychologic function
  publication-title: Pain
  doi: 10.1016/0304-3959(84)90884-4
– volume: 35
  start-page: 201
  year: 2019
  ident: 10.1016/j.pnpbp.2020.110148_bb0335
  article-title: Transcranial direct current stimulation on opium craving, depression, and anxiety: a preliminary study
  publication-title: J. ECT
  doi: 10.1097/YCT.0000000000000568
– volume: 10
  year: 2019
  ident: 10.1016/j.pnpbp.2020.110148_bb0350
  article-title: Effects of opioid dependence on visuospatial memory and its associations with depression and anxiety
  publication-title: Front. Psychiatry
  doi: 10.3389/fpsyt.2019.00743
– volume: 16
  start-page: 174
  year: 1997
  ident: 10.1016/j.pnpbp.2020.110148_bb0400
  article-title: Dopamine D2 receptor availability in opiate-dependent subjects before and after naloxone-precipitated withdrawal
  publication-title: Neuropsychopharmacology
  doi: 10.1016/S0893-133X(96)00184-4
– volume: 18
  start-page: 262
  year: 2008
  ident: 10.1016/j.pnpbp.2020.110148_bb0440
  article-title: Striatal dopamine D2 receptor binding and dopamine release during cue-elicited craving in recently abstinent opiate-dependent males
  publication-title: Eur. Neuropsychopharmacol.
  doi: 10.1016/j.euroneuro.2007.11.002
– year: 2008
  ident: 10.1016/j.pnpbp.2020.110148_bb0360
  article-title: Opioid pharmacology
  publication-title: Pain Physician.
  doi: 10.36076/ppj.2008/11/S133
– volume: 81
  year: 2018
  ident: 10.1016/j.pnpbp.2020.110148_bb0345
  article-title: Compulsivity in opioid dependence
  publication-title: Prog. Neuro-Psychopharmacol. Biol. Psychiatr.
  doi: 10.1016/j.pnpbp.2017.09.007
– year: 2019
  ident: 10.1016/j.pnpbp.2020.110148_bb0320
  article-title: Forging neuroimaging targets for recovery in opioid use disorder
  publication-title: Front. Psychiatry.
  doi: 10.3389/fpsyt.2019.00117
– volume: 36
  start-page: 3100
  year: 2015
  ident: 10.1016/j.pnpbp.2020.110148_bb0190
  article-title: Heroin abuse exaggerates age-related deposition of hyperphosphorylated tau and p62-positive inclusions
  publication-title: Neurobiol. Aging
  doi: 10.1016/j.neurobiolaging.2015.07.018
– volume: 165
  start-page: 390
  year: 2008
  ident: 10.1016/j.pnpbp.2020.110148_bb0200
  article-title: Acute effect of methadone maintenance dose on brain fMRI response to heroin-related cues
  publication-title: Am. J. Psychiatry
  doi: 10.1176/appi.ajp.2007.07010070
– volume: 83
  start-page: 4
  year: 1998
  ident: 10.1016/j.pnpbp.2020.110148_bb0295
  article-title: Opiates and infection
  publication-title: J. Neuroimmunol.
  doi: 10.1016/S0165-5728(97)00216-6
– year: 2020
  ident: 10.1016/j.pnpbp.2020.110148_bb0145
– year: 2019
  ident: 10.1016/j.pnpbp.2020.110148_bb0095
  article-title: Transcranial electrical and magnetic stimulation (tES and TMS) for addiction medicine: A consensus paper on the present state of the science and the road ahead
  publication-title: Neurosci. Biobehav. Rev.
  doi: 10.1016/j.neubiorev.2019.06.007
– year: 2019
  ident: 10.1016/j.pnpbp.2020.110148_bb0385
  article-title: A roadmap for integrating neuroscience into addiction treatmmeent: a consensus of the neuroscience Interest group of the international society of addiction medicine
  publication-title: Front. Psychiatry.
  doi: 10.3389/fpsyt.2019.00877
– volume: 39
  start-page: 131
  issue: 2
  year: 2018
  ident: 10.1016/j.pnpbp.2020.110148_bb0325
  article-title: Common biological mechanisms of alcohol use disorder and post-traumatic stress disorder
  publication-title: Alcohol Res. Curr. Rev.
– volume: 32
  start-page: 950
  year: 2007
  ident: 10.1016/j.pnpbp.2020.110148_bb0380
  article-title: Cognitive impulsivity in cocaine and heroin polysubstance abusers
  publication-title: Addict. Behav.
  doi: 10.1016/j.addbeh.2006.06.032
– volume: 71
  start-page: 223
  year: 2009
  ident: 10.1016/j.pnpbp.2020.110148_bb0430
  article-title: Gray matter density negatively correlates with duration of heroin use in young lifetime heroin-dependent individuals
  publication-title: Brain Cogn.
  doi: 10.1016/j.bandc.2009.08.014
– volume: 15
  start-page: 945
  year: 1997
  ident: 10.1016/j.pnpbp.2020.110148_bb4000
  article-title: Vasculitis owing to substance abuse
  publication-title: Neurol. Clin.
  doi: 10.1016/S0733-8619(05)70357-1
– volume: 8
  start-page: 123
  year: 2014
  ident: 10.1016/j.pnpbp.2020.110148_bb0330
  article-title: Patterns of brain activation during craving in heroin dependents successfully treated by methadone maintenance and abstinence-based treatments
  publication-title: J. Addict. Med.
  doi: 10.1097/ADM.0000000000000022
– volume: 1
  start-page: 349
  year: 1976
  ident: 10.1016/j.pnpbp.2020.110148_bb0265
  article-title: Neuronal depletion in the globus pallidus of heroin addicts
  publication-title: Drug Alcohol Depend.
  doi: 10.1016/0376-8716(76)90037-5
– volume: 190
  start-page: 517
  year: 2007
  ident: 10.1016/j.pnpbp.2020.110148_bb0370
  article-title: Profile of executive deficits in cocaine and heroin polysubstance users: common and differential effects on separate executive components
  publication-title: Psychopharmacology
  doi: 10.1007/s00213-006-0632-8
– volume: 184
  start-page: 139
  year: 2006
  ident: 10.1016/j.pnpbp.2020.110148_bb0240
  article-title: Prefrontal and temporal gray matter density decreases in opiate dependence
  publication-title: Psychopharmacology
  doi: 10.1007/s00213-005-0198-x
– volume: 45
  start-page: 108
  year: 2019
  ident: 10.1016/j.pnpbp.2020.110148_bb0065
  article-title: Self-awareness deficits associated with lower treatment motivation in cocaine addiction
  publication-title: Am. J. Drug Alcohol Abuse
  doi: 10.1080/00952990.2018.1511725
– volume: 36
  start-page: 2056
  year: 2012
  ident: 10.1016/j.pnpbp.2020.110148_bb0035
  article-title: Neuropsychological consequences of chronic opioid use: A quantitative review and meta-analysis
  publication-title: Neurosci. Biobehav. Rev.
  doi: 10.1016/j.neubiorev.2012.06.006
– year: 2014
  ident: 10.1016/j.pnpbp.2020.110148_bb0250
  article-title: Impaired self-awareness in human addiction: deficient attribution of personal relevance
  publication-title: Trends Cogn. Sci.
  doi: 10.1016/j.tics.2014.09.003
– volume: 30
  start-page: 2115
  year: 2005
  ident: 10.1016/j.pnpbp.2020.110148_bb3000
  article-title: Punishment induces risky decision-making in methadone-maintained opiate users but not in heroin users or healthy volunteers
  publication-title: Neuropsychopharmacology
  doi: 10.1038/sj.npp.1300812
– ident: 10.1016/j.pnpbp.2020.110148_bb0075
– year: 2009
  ident: 10.1016/j.pnpbp.2020.110148_bb0020
  article-title: Mechanisms of change in motivational interviewing: a review and preliminary evaluation of the evidence
  publication-title: Addiction.
  doi: 10.1111/j.1360-0443.2009.02527.x
– volume: 12
  start-page: 652
  year: 2011
  ident: 10.1016/j.pnpbp.2020.110148_bb0120
  article-title: Dysfunction of the prefrontal cortex in addiction: neuroimaging findings and clinical implications
  publication-title: Nat. Rev. Neurosci.
  doi: 10.1038/nrn3119
– volume: 49
  start-page: 1174
  issue: 7
  year: 2019
  ident: 10.1016/j.pnpbp.2020.110148_bb2200
  article-title: Profiles of visuospatial memory dysfunction in opioid-exposed and dependent populations
  publication-title: Psychol. Med.
  doi: 10.1017/S0033291718003318
– year: 1979
  ident: 10.1016/j.pnpbp.2020.110148_bb0055
– volume: 83
  start-page: 163
  year: 2006
  ident: 10.1016/j.pnpbp.2020.110148_bb0275
  article-title: Impaired decision-making in opiate-dependent subjects: effect of pharmacological therapies
  publication-title: Drug Alcohol Depend.
  doi: 10.1016/j.drugalcdep.2005.11.008
– start-page: 12
  year: 2004
  ident: 10.1016/j.pnpbp.2020.110148_bb0130
  article-title: Comorbidity of alcohol
  publication-title: Drug Psychiatr. Disord.
– start-page: 239
  year: 2017
  ident: 10.1016/j.pnpbp.2020.110148_bb8000
  article-title: Neuroscience-informed psychoeducation for addiction medicine: A neurocognitive perspective
  doi: 10.1016/bs.pbr.2017.08.013
– year: 2018
  ident: 10.1016/j.pnpbp.2020.110148_bb0210
– volume: 4
  year: 2013
  ident: 10.1016/j.pnpbp.2020.110148_bb0090
  article-title: Association of frontal gray matter volume and cerebral perfusion in heroin addiction: a multimodal neuroimaging study
  publication-title: Front. Psychiatry
  doi: 10.3389/fpsyt.2013.00135
– volume: 81
  start-page: 354
  year: 2009
  ident: 10.1016/j.pnpbp.2020.110148_bb5000
  article-title: Severe non-occlusive ischemic stroke in young heroin addicts
  publication-title: Acta Neurol. Scand.
  doi: 10.1111/j.1600-0404.1990.tb01570.x
– volume: 3
  start-page: 432
  year: 1995
  ident: 10.1016/j.pnpbp.2020.110148_bb0435
  article-title: A review of the effects of opioids on psychomotor and cognitive functioning in humans
  publication-title: Exp. Clin. Psychopharmacol.
  doi: 10.1037/1064-1297.3.4.432
– year: 2013
  ident: 10.1016/j.pnpbp.2020.110148_bb0010
– volume: 46
  start-page: 2841
  year: 2016
  ident: 10.1016/j.pnpbp.2020.110148_bb0340
  article-title: Multifaceted impairments in impulsivity and brain structural abnormalities in opioid dependence and abstinence
  publication-title: Psychol. Med.
  doi: 10.1017/S0033291716001513
– volume: 20
  start-page: 80
  year: 2019
  ident: 10.1016/j.pnpbp.2020.110148_bb0005
  article-title: Chasing the wrong dragon: a new presentation of heroin-induced toxic leukoencephalopathy mimicking anoxic brain injury
  publication-title: J. Intensiv. Care Soc.
  doi: 10.1177/1751143718774714
– volume: 16
  start-page: 250
  year: 2013
  ident: 10.1016/j.pnpbp.2020.110148_bb0260
  article-title: Repeat dose opioids May be effective for breathlessness in chronic heart failure if given for long enough
  publication-title: J. Palliat. Med.
  doi: 10.1089/jpm.2012.0270
– volume: 188
  start-page: 364
  year: 2006
  ident: 10.1016/j.pnpbp.2020.110148_bb0105
  article-title: Differences in orbitofrontal activation during decision-making between methadone-maintained opiate users, heroin users and healthy volunteers
  publication-title: Psychopharmacology
  doi: 10.1007/s00213-006-0515-z
– year: 2015
  ident: 10.1016/j.pnpbp.2020.110148_bb0110
  article-title: Understanding opioid reward
  publication-title: Trends Neurosci.
  doi: 10.1016/j.tins.2015.01.002
– volume: 108
  start-page: 587
  year: 2002
  ident: 10.1016/j.pnpbp.2020.110148_bb0155
  article-title: Opioid tolerance-in search of the holy grail
  publication-title: Cell
  doi: 10.1016/S0092-8674(02)00666-9
– volume: 131
  start-page: 135
  year: 2004
  ident: 10.1016/j.pnpbp.2020.110148_bb0235
  article-title: White matter hyperintensities in subjects with cocaine and opiate dependence and healthy comparison subjects
  publication-title: Psychiatry Res.
  doi: 10.1016/j.pscychresns.2004.04.001
– volume: 3
  start-page: 760
  year: 2016
  ident: 10.1016/j.pnpbp.2020.110148_bb0180
  article-title: Neurobiology of addiction: a neurocircuitry analysis
  publication-title: Lancet Psychiatry
  doi: 10.1016/S2215-0366(16)00104-8
– volume: 63
  start-page: 563
  year: 2009
  ident: 10.1016/j.pnpbp.2020.110148_bb0225
  article-title: Frontal and cingulate gray matter volume reduction in heroin dependence: optimized voxel-based morphometry
  publication-title: Psychiatry Clin. Neurosci.
  doi: 10.1111/j.1440-1819.2009.01989.x
– year: 2019
  ident: 10.1016/j.pnpbp.2020.110148_bb0230
  article-title: Efficacy of invasive and non-invasive brain modulation interventions for addiction
  publication-title: Neuropsychol. Rev.
  doi: 10.1007/s11065-018-9393-5
– volume: 102
  start-page: 51
  year: 1999
  ident: 10.1016/j.pnpbp.2020.110148_bb0015
  article-title: Hypoxic/ischaemic brain damage, especially pallidal lesions, in heroin addicts
  publication-title: Forensic Sci. Int.
  doi: 10.1016/S0379-0738(99)00040-7
– volume: 102
  start-page: 937
  year: 2007
  ident: 10.1016/j.pnpbp.2020.110148_bb2000
  article-title: Implicit learning, executive function and hedonic activity in chronic polydrug abusers, currently abstinent polydrug abusers and controls
  publication-title: Addiction
  doi: 10.1111/j.1360-0443.2007.01823.x
– volume: 45
  start-page: 1167
  year: 2015
  ident: 10.1016/j.pnpbp.2020.110148_bb0040
  article-title: Impulsivity and opioid drugs: differential effects of heroin, methadone and prescribed analgesic medication
  publication-title: Psychol. Med.
  doi: 10.1017/S0033291714002189
– start-page: 1
  year: 2003
  ident: 10.1016/j.pnpbp.2020.110148_bb0205
  article-title: Relapse prevention an overview of Marlatt’s cognitive-behavioral model
SSID ssj0001303
Score 2.4406695
SecondaryResourceType review_article
Snippet The incidence of chronic heroin use disorder, including overdose deaths, has reached epidemic proportions. Here we summarise and evaluate our knowledge of the...
SourceID proquest
pubmed
crossref
elsevier
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 110148
SubjectTerms Bipolar Disorder
Brain - physiopathology
Cognitive Dysfunction
Comorbidity
fMRI
Heroin
Heroin - adverse effects
Humans
Impulsive Behavior
Interventions
Neurocognition
Neuroimaging
Neurology
Neuroscience
Neurosciences
Opioid-Related Disorders - physiopathology
Psychotic Disorders
sMRI
Title Chronic heroin use disorder and the brain: Current evidence and future implications
URI https://dx.doi.org/10.1016/j.pnpbp.2020.110148
https://www.ncbi.nlm.nih.gov/pubmed/33169674
https://www.proquest.com/docview/2459349491
Volume 111
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LS8QwEB50vXgR364vIoinrZsmaWK9iSirogiu4C00j8KKdBd39-DF326SpquCevDaJmmaSb6ZZCbfABxqYYRQJk98bp2ElYVyS8qqxGluXhaE2jIcZd_e8d4ju37KnubgvLkL48MqI_bXmB7QOj7pxtHsjgaD7oP3mXn1SYJ3j7F5WCA051kLFs6ubnp3M0D2MB2OWoS_ZMR4Qz4UwrxG1Uh53koSIuJTnwfoZwX1mwEaFNHlMixFCxKd1Z1cgTlbrcLRfU1B_dZB_c8bVeMOOkL3n-TUb2vwENlwkSs1HFRoOrbIRAZOVFQGOYMQKZ834hRF7iZkY-bR8L4mIUGDL5Ho69C_vOif95KYWCHRDLNJQixlQhFNTKrK0u2BseVKFzg1luVEqROKtVD5SY6xoZSWSihcEl0IgZnSgm5AqxpWdgsQx1rTjBoiiHJbQ5bbzLXjbGBWGt9gG0gzmFJH0nGf--JFNtFlzzJIQHoJyFoCbejMKo1qzo2_i_NGSvLb1JFOK_xd8aCRqXSLyntKisoOp2NJWJYH3h73A5u1sGc9oTTlORds-7-f3YFF4gNjUuIgahdak9ep3XOWzUTtw_zxe7of5-8H0Ib3tA
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3NT8MgFCdTD3oxfjs_MTGeVkeBltWbMZr5tSxxJruR8tGkxnSN2w5e_NsFSp0muoPXFijlwXsP3o_fA-BUMsWYUElgc-sENEuFWVJaBMZyx1mKic7cUfZjL-4-07thNGyAq_oujIVVet1f6XSnrf2Tth_Ndpnn7ScbM7PmE7voHqULYIlGhFlc3_nHDOdhlbQ7aGH2ihGNa-ohB_Iqi1JY1krs8PChzQL0u3n6y_10ZuhmDax6_xFeVl1cBw1dbICzfkVA_d6Cg9l9qnELnsH-jJr6fRM8eS5caEqN8gJOxxoqz78J00JB4w5CYbNGXEDP3AS1zzvq3lcUJDD_hkPfAoOb68FVN_BpFQJJEZ0EWBPKBJZYhSLLzA4Y6VjIFIVK0wQL0SFIMpF0EoQUISQTTKAMy5QxRIVkZBssFqNC7wIYIylJRBRmWJiNIU10ZNoxHjDNlG2wCXA9mFx6ynGb-eKV19iyF-4kwK0EeCWBJmh9VSorxo35xeNaSvzHxOHGJsyveFLLlJslZeMkaaFH0zHHNEoca4_5gZ1K2F89ISSMk5jRvf9-9hgsdwePD_zhtne_D1awhciE2CirA7A4eZvqQ-PjTMSRm8Of6Lf4fw
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Chronic+heroin+use+disorder+and+the+brain%3A+Current+evidence+and+future+implications&rft.jtitle=Progress+in+neuro-psychopharmacology+%26+biological+psychiatry&rft.au=Tolomeo%2C+Serenella&rft.au=Steele%2C+J+Douglas&rft.au=Ekhtiari%2C+Hamed&rft.au=Baldacchino%2C+Alex&rft.date=2021-12-20&rft.issn=1878-4216&rft.eissn=1878-4216&rft.volume=111&rft.spage=110148&rft_id=info:doi/10.1016%2Fj.pnpbp.2020.110148&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0278-5846&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0278-5846&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0278-5846&client=summon